This retrospective observational study evaluates the long-term safety and efficacy of tocilizumab, a humanized antibody targeting the interleukin 6 receptor, in 8 female patients with neuromyelitis optica (NMO) and NMO spectrum disorder. See the Editorial by Vincent.
↧